Interleukin-19 ameliorates drug-induced liver injury by limiting proinflammatory macrophage infiltration via SUMOylation of C/EBPβ
- 18 June 2026
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 85 (5) , 868-881
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 34 references indexed in Scilit:
- Dose-dependent pleiotropic role of neutrophils during acetaminophen-induced liver injury in male and female miceArchives of Toxicology, 2023
- G-CSF exacerbates liver injury in a mouse model of autoimmune hepatitisJournal of Hepatology, 2022
- Combination of G-CSF and a TLR4 inhibitor reduce inflammation and promote regeneration in a mouse model of ACLFJournal of Hepatology, 2022
- Recommendations for the use of the acetaminophen hepatotoxicity model for mechanistic studies and how to avoid common pitfallsActa Pharmaceutica Sinica B, 2021
- IL‐19 induced by IL‐13/IL‐17A in the nasal epithelium of patients with chronic rhinosinusitis upregulates MMP‐9 expression via ERK/NF‐κB signaling pathwayClinical and Translational Allergy, 2021
- Interleukin-20 exacerbates acute hepatitis and bacterial infection by downregulating IκBζ target genes in hepatocytesJournal of Hepatology, 2021
- Alcohol and drug-induced liver injury: Metabolism, mechanisms, pathogenesis and potential therapiesLiver Research, 2019
- Chemokine (C‐C motif) receptor 2–positive monocytes aggravate the early phase of acetaminophen‐induced acute liver injuryHepatology, 2016
- Regulation of C/EBPβ and resulting functions in cells of the monocytic lineageCellular Signalling, 2012
- The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulationCytokine, 2011